Glisoxepide

DB01289

small molecule investigational

Deskripsi

Glisoxepide is one of the sulphonamide-derived oral antidiabetic drugs. It inhibits the uptake of bile acids into isolated rat hepatocytes. However it inhibits taurocholate uptake only in the absence of sodium ions. Glisoxepide uptake could be further inhibited by blockers of the hepatocellular monocarboxylate transporter, by the loop diuretic bumetanide, by 4,4'-diisothiocyano-2,2'-stilbenedisulfonate (DIDS) and by sulphate. These results are consistent with the transport of glisoxepide via the transport system for the unconjugated bile acid cholate. A31819,A31820

Struktur Molekul 2D

Berat 449.524
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1035 Data
Pegvisomant The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glisoxepide.
Carbocisteine The risk or severity of adverse effects can be increased when Glisoxepide is combined with Carbocisteine.
Chloramphenicol The metabolism of Glisoxepide can be decreased when combined with Chloramphenicol.
Cimetidine The serum concentration of Glisoxepide can be increased when it is combined with Cimetidine.
Fluconazole The serum concentration of Glisoxepide can be increased when it is combined with Fluconazole.
Metreleptin Metreleptin may increase the hypoglycemic activities of Glisoxepide.
Probenecid The protein binding of Glisoxepide can be decreased when combined with Probenecid.
Ranitidine The serum concentration of Glisoxepide can be increased when it is combined with Ranitidine.
Voriconazole The serum concentration of Glisoxepide can be increased when it is combined with Voriconazole.
Clarithromycin The serum concentration of Glisoxepide can be increased when it is combined with Clarithromycin.
Lipoic acid The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glisoxepide.
Rifampin The serum concentration of Glisoxepide can be decreased when it is combined with Rifampicin.
Moxifloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Moxifloxacin.
Grepafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Grepafloxacin.
Enoxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Enoxacin.
Pefloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Pefloxacin.
Ciprofloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Ciprofloxacin.
Trovafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Trovafloxacin.
Nalidixic acid The therapeutic efficacy of Glisoxepide can be increased when used in combination with Nalidixic acid.
Rosoxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Rosoxacin.
Cinoxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Cinoxacin.
Lomefloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Lomefloxacin.
Gatifloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gatifloxacin.
Norfloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Norfloxacin.
Levofloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Levofloxacin.
Gemifloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gemifloxacin.
Ofloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Ofloxacin.
Sparfloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sparfloxacin.
Temafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Temafloxacin.
Fleroxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Fleroxacin.
Technetium Tc-99m ciprofloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
Garenoxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Garenoxacin.
Nemonoxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Nemonoxacin.
Flumequine The therapeutic efficacy of Glisoxepide can be increased when used in combination with Flumequine.
Enrofloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Enrofloxacin.
Orbifloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Orbifloxacin.
Sarafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sarafloxacin.
Difloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Difloxacin.
Pazufloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Pazufloxacin.
Prulifloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Prulifloxacin.
Delafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Delafloxacin.
Sitafloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sitafloxacin.
Oxolinic acid The therapeutic efficacy of Glisoxepide can be increased when used in combination with Oxolinic acid.
Rufloxacin The therapeutic efficacy of Glisoxepide can be increased when used in combination with Rufloxacin.
Pipemidic acid The therapeutic efficacy of Glisoxepide can be increased when used in combination with Pipemidic acid.
Methyclothiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Methyclothiazide.
Chlorthalidone The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Chlorthalidone.
Bendroflumethiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Bendroflumethiazide.
Metolazone The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Metolazone.
Benzthiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Benzthiazide.
Hydroflumethiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydroflumethiazide.
Indapamide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Indapamide.
Chlorothiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Chlorothiazide.
Hydrochlorothiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydrochlorothiazide.
Trichlormethiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Trichlormethiazide.
Polythiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Polythiazide.
Quinethazone The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Quinethazone.
Cyclopenthiazide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Cyclopenthiazide.
Epitizide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Epitizide.
Esmolol Esmolol may increase the hypoglycemic activities of Glisoxepide.
Landiolol Landiolol may increase the hypoglycemic activities of Glisoxepide.
Ethanol The risk or severity of adverse effects can be increased when Glisoxepide is combined with Ethanol.
Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Glisoxepide.
Protriptyline Protriptyline may decrease the hypoglycemic activities of Glisoxepide.
Imipramine Imipramine may decrease the hypoglycemic activities of Glisoxepide.
Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Glisoxepide.
Amoxapine Amoxapine may decrease the hypoglycemic activities of Glisoxepide.
Desipramine Desipramine may decrease the hypoglycemic activities of Glisoxepide.
Clomipramine Clomipramine may decrease the hypoglycemic activities of Glisoxepide.
Amineptine Amineptine may decrease the hypoglycemic activities of Glisoxepide.
Dimetacrine Dimetacrine may decrease the hypoglycemic activities of Glisoxepide.
Butriptyline Butriptyline may decrease the hypoglycemic activities of Glisoxepide.
Dosulepin Dosulepin may decrease the hypoglycemic activities of Glisoxepide.
Tianeptine Tianeptine may decrease the hypoglycemic activities of Glisoxepide.
Oxaprotiline Oxaprotiline may decrease the hypoglycemic activities of Glisoxepide.
Opipramol Opipramol may decrease the hypoglycemic activities of Glisoxepide.
Amitriptylinoxide Amitriptylinoxide may decrease the hypoglycemic activities of Glisoxepide.
Dibenzepin Dibenzepin may decrease the hypoglycemic activities of Glisoxepide.
Quinupramine Quinupramine may decrease the hypoglycemic activities of Glisoxepide.
Melitracen Melitracen may decrease the hypoglycemic activities of Glisoxepide.
Lofepramine Lofepramine may decrease the hypoglycemic activities of Glisoxepide.
Iprindole Iprindole may decrease the hypoglycemic activities of Glisoxepide.
Imipramine oxide Imipramine oxide may decrease the hypoglycemic activities of Glisoxepide.
Doxepin Doxepin may decrease the hypoglycemic activities of Glisoxepide.
Clofibrate The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glisoxepide.
Fenofibrate The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glisoxepide.
Bezafibrate The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glisoxepide.
Etofibrate The risk or severity of hypoglycemia can be increased when Etofibrate is combined with Glisoxepide.
Ciprofibrate The risk or severity of hypoglycemia can be increased when Ciprofibrate is combined with Glisoxepide.
Simfibrate The risk or severity of hypoglycemia can be increased when Simfibrate is combined with Glisoxepide.
Ronifibrate The risk or severity of hypoglycemia can be increased when Ronifibrate is combined with Glisoxepide.
Aluminium clofibrate The risk or severity of hypoglycemia can be increased when Aluminium clofibrate is combined with Glisoxepide.
Clofibride The risk or severity of hypoglycemia can be increased when Clofibride is combined with Glisoxepide.
Fenofibric acid The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glisoxepide.
Miconazole The serum concentration of Glisoxepide can be increased when it is combined with Miconazole.
Phenindione Glisoxepide may increase the anticoagulant activities of Phenindione.
Coumarin Glisoxepide may increase the anticoagulant activities of Coumarin.
(R)-warfarin Glisoxepide may increase the anticoagulant activities of (R)-warfarin.
Clorindione Glisoxepide may increase the anticoagulant activities of Clorindione.
Diphenadione Glisoxepide may increase the anticoagulant activities of Diphenadione.

Target Protein

ATP-sensitive inward rectifier potassium channel 10 KCNJ10
ATP-sensitive inward rectifier potassium channel 8 KCNJ8
Insulin INS

Referensi & Sumber

Synthesis reference: U.S. Patent 3,668,215.
Artikel (PubMed)
  • PMID: 1618280
    Fuckel D, Petzinger E: Interaction of sulfonylureas with the transport of bile acids into hepatocytes. Eur J Pharmacol. 1992 Mar 31;213(3):393-404.
  • PMID: 9017793
    Selvaag E: Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere. Photodermatol Photoimmunol Photomed. 1996 Aug;12(4):166-70.

Contoh Produk & Brand

Produk: 0 • International brands: 3
International Brands
  • Glucoben — Farmades
  • Glysepin — Bayer
  • Pro-Diaban — Bayer

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul